William David Haydon - 06 Mar 2023 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, GM Pain Franchise
Signature
/s/ Mojirade James, as attorney-in-fact for William D. Haydon
Issuer symbol
AVNS
Transactions as of
06 Mar 2023
Net transactions value
-$44,815
Form type
4
Filing time
07 Mar 2023, 15:42:06 UTC
Previous filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Tax liability $44,815 -1,513 -5.1% $29.62 28,443 06 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.
F2 Total beneficially owned includes 140 shares acquired on December 30, 2022 and 595 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan.